The importance of PGP in doxorubicin-resistance has been investigated using the PGP inhibitor tariquidar in Brca1−/−;p53−/− mammary tumours generated in K14cre;Brca1−/−;p53−/− mice [39]. The gene discussed is TP53; the disease is breast cancer.